The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/IIa trial to evaluate the safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced NSCLC.
 
Chunjiao Wu
No Relationships to Disclose
 
Dongqing Lv
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Zhen Wang
No Relationships to Disclose
 
Hui Zhao
No Relationships to Disclose
 
Huaxin Duan
No Relationships to Disclose
 
Ping Duan
No Relationships to Disclose
 
Yongmei Yin
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Fu-Nan Liu
No Relationships to Disclose
 
Chuize Kong
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Yongsheng Li
No Relationships to Disclose
 
Xinpeng Han
No Relationships to Disclose
 
Baogang Liu
No Relationships to Disclose
 
Lijie He
No Relationships to Disclose
 
Zhiquan Qin
No Relationships to Disclose
 
Tao Wu
No Relationships to Disclose
 
Mei Ji
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose